April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Development of Soft Contact Lens for Drug Delivery Using Zwitter Ionic Hydrogel
Author Affiliations & Notes
  • Toru Matsunaga
    Reserch and Development, Seed Co Ltd, Saitama, Japan
    Department of Ophthalmology, Juntendo University Graduate School of Medicine, Tokyo, Japan
  • Tomomi Tashiro
    Reserch and Development, Seed Co Ltd, Saitama, Japan
  • Takao Sato
    Reserch and Development, Seed Co Ltd, Saitama, Japan
  • Toshinari Funaki
    Department of Ophthalmology, Juntendo University Graduate School of Medicine, Tokyo, Japan
  • Akira Murakami
    Department of Ophthalmology, Juntendo University Graduate School of Medicine, Tokyo, Japan
  • Footnotes
    Commercial Relationships Toru Matsunaga, SEED Co., Ltd. (E); Tomomi Tashiro, SEED Co., Ltd. (E); Takao Sato, SEED Co., Ltd. (E); Toshinari Funaki, None; Akira Murakami, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 6050. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Toru Matsunaga, Tomomi Tashiro, Takao Sato, Toshinari Funaki, Akira Murakami; Development of Soft Contact Lens for Drug Delivery Using Zwitter Ionic Hydrogel. Invest. Ophthalmol. Vis. Sci. 2014;55(13):6050.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: As drug delivery system device in the treatment of eye diseases, using soft contact lens (SCL) have been investigated and approached for a long time. However, the sustained and selective release of drug have not been secured because the interaction of SCL with the drug varies depending on the each characteristics. Furthermore, drug delivery system SCL (DDSSCL) should be kept the stable shape in order to ensure the vision correction. From our evaluation about the interaction of SCL with ophthalmic solutions, we have found the zwitter ionic material is stable in ophthalmic solutions. For the purpose of this study, as a base of material with the zwitter ionic hydrogel, we developed and evaluated the DDSSCL using an ion-exchange reaction.

Methods: By using a monomer having a quaternary ammonium salt group and a carboxyl group as ionic monomer, ionic hydrogel different in ration of each ionic monomer were produced and DDSSCL were produced to soak the ionic hydrogel in the drug solution. Disodium cromoglycate (DSCG) was used as a model drug because it has a long history for allergic conjunctivitis treatment drug. The produced DDSSCL was soaked in phosphate buffer and was observed the lens shape. In addition, released DSCG from the DDSSCL were measured with high pressure liquid chromatography in the every given time and evaluated the release behavior. Furthermore, the evaluation of DDSSCL in vivo measured DSCG concentration of tear in the every given time after wearing it on Japanese white rabbit eyes, and compared the data with the case of treatment by ophthalmic solutions.

Results: The uptake quantity of DSCG for DDSSCL increased depending on the ration of the quaternary ammonium salt group and the release behavior was observed over 8 hours or more. In addition, DDSSCL having both ionic group were keep the shape, but it having only one ionic group were observed deformation. Moreover, DSCG concentration of tears were decreased in a short time after instillation, but they were kept more than 8 hours in DDSSCL wearing groups.

Conclusions: The DDSSCL as a base of material with the zwitter ionic hydrogel is useful device as having to ensure the vision correction and the high safety drug delivery system becasuse the device is possible sustained drug release and to keep the shape.

Keywords: 477 contact lens • 497 development • 503 drug toxicity/drug effects  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×